Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, is a dual GIP and GLP-1 receptor agonist that has transformed metabolic disease treatment
We focus on their molecular mechanisms in GSH metabolism, their roles in ER stress and ferroptosis, their dual functions in cancer and their impact on stem cell dynamics and neurodegenerative pathways
Allow to air dry several seconds before inserting needle
Response-Based Approach: Treatment duration is individualized based on objective measurements including body composition analysis (DEXA scan, bioimpedance), waist circumference, metabolic markers, and subjective response
Additionally, tirzepatide improves insulin sensitivity and glucose metabolism, which contributes to its metabolic benefits beyond weight reduction
Figure 1 PCOS symptoms can be seen in youngsters